Search
for
Sort by
Research 361–390 of 534
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin
- Annular alopecia areata: Report of two cases
- The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S) in the majority of the alopecia areata patients: Is it a primitive and pathogenic perturbation of hypothalamic-pituitary-adrenal axis?
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
- Photobiomodulation for Skin Pigmentation Disorders: A Dual-Function Treatment
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- Exploring the effect of hsa-miR-19b-3p on IL-1R1 expression and serum levels in alopecia areata
- Immune Regulation in Hair Follicle Protection and Hair Regeneration: Insights from the Collapse of Immune Privilege in Alopecia Areata and Targeted Immunotherapy
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Bacteroides fragilis and Microbacterium as Microbial Signatures in Hashimoto’s Thyroiditis
- DISRUPTION OF HAIR FOLLICLE IMMUNE PRIVILEGE IN ALOPECIA AREATA: ENIGMATIC MECHANISMS AND EMERGING CONCEPTS
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- S3301 Abnormal Liver Enzymes in Thymoma-Associated Multiorgan Autoimmunity
- Coexistence of dermatomyositis and alopecia areata: Insight into pathogenesis